PARP1-Dependent and Independent Pathways for Resolution of Trapped Topoisomerase I Covalent Complexes

Area of Science:

• Molecular Biology
• Genetics
• Cancer Research

Background:

• Topoisomerase I (Top1) manages DNA supercoiling but can be trapped by chemotherapeutics like camptothecin (CPT), forming Top1-DNA covalent complexes (Top1cc).
• Resolution of Top1cc is vital to prevent DNA breaks, replication stress, and cell death.
• Poly (ADP-ribose) polymerase 1 (PARP1) is a known sensor of Top1cc, recruiting tyrosyl-DNA phosphodiesterase 1 (TDP1) for repair.

Purpose of the Study:

• To review the PARP1-dependent and independent pathways for Topoisomerase I-DNA covalent complex (Top1cc) repair.
• To explore the interplay and redundancy between these repair mechanisms.
• To discuss the therapeutic potential of targeting Top1cc repair pathways in cancer treatment.

Main Methods:

• Literature review of Topoisomerase I-DNA covalent complex (Top1cc) repair mechanisms.
• Analysis of PARP1-dependent and independent pathways.
• Synthesis of current research on repair pathway interplay and therapeutic implications.

Main Results:

• PARP1 acts as a molecular switch, influencing the choice between TDP1 and endonuclease pathways for Top1cc repair.
• PARP1-independent repair mechanisms, including endonucleolytic cleavage and proteolytic degradation, also contribute to Top1cc resolution.
• Interplay and redundancy exist between different Top1cc repair pathways.

Conclusions:

• Targeting Top1cc repair pathways, both PARP1-dependent and independent, offers potential to enhance Topoisomerase I-based cancer therapies.
• Understanding these pathways may help overcome therapeutic resistance.
• Further research into the complex interplay of Top1cc repair mechanisms is warranted for improved cancer treatment strategies.